Transcriptional Regulation by Activation and Repression Elements
Located at the 5-Noncoding Region of the Human 9 Nicotinic
Receptor Subunit Gene*
Received for publication, July 2, 2003, and in revised form, July 14, 2003
Published, JBC Papers in Press, July 14, 2003, DOI 10.1074/jbc.M307043200
Luis M. Valor‡, Mar Castillo§, Jose ´ A. Ortiz¶, and Manuel Criado
From the Department of Biochemistry and Molecular Biology and the Instituto de Neurociencias, Universidad Miguel
Herna ´ndez-Consejo Superior de Investigaciones Cientı´ficas, 03550 San Juan, Alicante, Spain
The 9 subunit is a component of the neuronal nico-
tinic acetylcholine receptor gene superfamily that is ex-
pressed in very restricted locations. The promoter of the
human gene has been analyzed in the human neuroblas-
toma SH-SY5Y, where 9 subunit expression was de-
tected, and in C2C12 cells that do not express 9. A
proximal promoter region (from 322 to 113) showed
maximal transcriptional activity in SH-SY5Y cells,
whereas its activity in C1C12 cells was much lower. Two
elements unusually located at the 5-noncoding region
exhibited opposite roles. A negative element located be-
tween 15 and 48 appears to be cell-specific because it
was effective in C2C12 but not in SH-SY5Y cells, where it
was counterbalanced by the presence of the promoter
region 5 to the initiation site. An activating element
located between 66 and 79 and formed by two adja-
cent Sox boxes increased the activity of the 9 promoter
about 4-fold and was even able to activate other promot-
ers. This element interacts with Sox proteins, probably
through a cooperative mechanism in which the two Sox
boxes are necessary. We propose that the Sox complex
provides an initial scaffold that facilitates the recruiting
of the transcriptional machinery responsible for 9 sub-
unit expression.
Neuronal nicotinic acetylcholine receptors (nAChRs)
1
are
members of a supergene family of ion channels gated by neu-
rotransmitters (1). They are pentameric oligomers composed of
related subunits, which are commonly classified as agonist-
binding (designated 2–10) and structural (2–4) subunits.
Unlike some nAChR subunits that have a relatively broad
expression, the 9 subunit has been found only in very re-
stricted areas such as the pituitary pars tuberalis, the olfactory
epithelium, and the cochlea (2, 3). This limited expression could
be the consequence of tight mechanisms of transcriptional reg-
ulation, which might be of great interest in understanding how
the regional and developmental expression of neuronal
nAChRs is controlled at the transcriptional level (see Ref. 4 for
a review). For this reason, here we have analyzed the human
9 promoter, finding that two cis-elements unusually located at
the 5'-noncoding region of 9 transcripts control in opposite
ways the basal transcriptional activity of the 9 subunit gene.
EXPERIMENTAL PROCEDURES
Isolation and Analysis of the 5'-Flanking Sequence of the 9 Sub-
unit—The human 9 coding sequence was obtained by PCR from a
human pituitary cDNA library (Clontech, Heidelberg, Germany) by
using the information contained in the GenBank
TM
sequence
AJ243342. A fragment from the 5'-end was used to screen a human
genomic library constructed in EMBL-3 SP6/T7 (Clontech) and tested
as described previously (5). A bacteriophage clone was purified and
characterized. It contained 4,600 bp of 5'-flanking region and at least
the first exon.
5'-RACE Analysis of 5' mRNA Ends—The 5'-end of 9 mRNA was
mapped by 5'-RACE, as primer extension and RNase protection meth-
ods did not yield satisfactory results. For this purpose the Marathon
Ready cDNA system from Clontech was applied to the previously men-
tioned cDNA library from human pituitary as indicated by the manu-
facturer. Two antisense oligonucleotides at the first and second exons
(see Fig. 1) were used in parallel assays of DNA amplification. Their
sequences were: from position +201 to +180, 5'-CTCAGTCTGGAAG-
CAGCAAAG-3'; +602 to +578, 5'-CGTAATCTGCAGG-GTCACAT-
TCAGG-3'. The resulting products were cloned and sequenced.
RT-PCR Analysis—Poly (A)
+
RNA was directly selected from SH-
SY5Y cell lysates by oligo(dT)-Dynabeads (Dynal, Oslo, Norway) accord-
ing to the manufacturer’s instructions. 9 subunit transcripts, as well
as 7 and 4 transcripts as positive controls, were detected by an
RT-PCR assay (Access RT-PCR System from Promega, Madison, WI).
Briefly, samples of mRNA (200 ng) or in vitro synthesized cRNA (30 ng)
in a final volume of 20 l were reverse transcribed with 2 units of avian
myeloblastosis virus (AMV) reverse transcriptase (45 min at 48 °C), and
PCR was further performed for 30 cycles (30 s at 94 °C, 45 s at 60 °C,
and 1 min at 68 °C) with 2 units of Tfl DNA polymerase. The amplified
DNA fragments extended over at least 1 intron or more, to rule out the
possibility of amplifying a potential contamination of genomic DNA.
Anyway, RT-PCR performed in the absence of AMV reverse tran-
scriptase or RNA did not yield any DNA fragment. A similar analysis
was performed with mRNA from C2C12 cells and 35 PCR cycles, and 7
but not 9 transcripts were detected.
Plasmid Constructions—All 9 promoter-luciferase gene fusions
were made in the pGL2-Basic vector (Promega), introducing in its
polylinker upstream of the luciferase gene the suitable 9 promoter
fragments. These fragments were generated with restriction enzymes
and cloned directly into pGL2-Basic or subcloned first in pBluescript
and then transferred to pGL2-Basic. Deletion analysis of the most
promoter-proximal region was performed by generating either appro-
priate restriction enzyme fragments or PCR fragments with suitable
sense oligonucleotides and an antisense primer (5'-CTTTATGTTTTT-
* This work was supported by grants from the Ministries of Educa-
tion (PM98-0104) and Science and Technology (BMC2002-00972) of
Spain and from the Generalitat Valenciana (CTIDIB/2002/138). The
costs of publication of this article were defrayed in part by the payment
of page charges. This article must therefore be hereby marked “adver-
tisement” in accordance with 18 U.S.C. Section 1734 solely to indicate
this fact.
The nucleotide sequence(s) reported in this paper has been submitted
to the GenBank
TM
/EBI Data Bank with accession number(s)
AJ576315.
‡ Recipient of predoctoral fellowships from the Generalitat Valenci-
ana and Consejo Superior de Investigaciones Cientı ´ficas-Bancaja.
§ Recipient of a fellowship from the Ministry of Science and Technol-
ogy (MCyT) of Spain.
¶ Supported by a grant from the MCyT of Spain (‘‘Ramo ´n y Cajal’’
program).
To whom correspondence should be addressed. Tel.: 34-965919479;
Fax: 34-965919484; E-mail: Manuel.Criado@umh.es.
1
The abbreviations used are: nAChR, nicotinic acetylcholine recep-
tor; HMG, high mobility group; GST, glutathione S-transferase; RACE,
rapid amplification of cDNA ends; RT-PCR, reverse transcription PCR.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 39, Issue of September 26, pp. 37249 –37255, 2003
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 37249
by guest on May 27, 2020 http://www.jbc.org/ Downloaded from